Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence

L R Yu1, X X Shao, W L Jiang

  • 1Research Center for Proteome, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, PR China.

Electrophoresis
|September 22, 2001
PubMed

Insights

Investigating human hepatoma cells, this study analyzed proteome changes after reducing the epidermal growth factor receptor (EGFR) pathway. Key proteins like maspin and HSP27 showed altered expression, offering insights into cancer growth.

Area of Science:

  • Proteomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Epidermal growth factor (EGF) stimulates cell proliferation.
  • Overexpression of the EGF receptor (EGFR) is common in cancers.
  • Targeting EGFR can suppress hepatoma cell growth.

Purpose of the Study:

  • To investigate proteome alterations in human hepatoma cells with reduced EGFR signaling.
  • To understand the influence of the EGFR pathway on cellular proteome dynamics.

Main Methods:

  • Comparative proteomic analysis using two-dimensional (2-D) gel electrophoresis.
  • Mass spectrometry for protein identification.
  • Analysis of human hepatoma cell strains JX-1 (antisense EGFR) and JX-0 (control).

Main Results:

  • 40 protein spots exhibited significant expression changes in JX-1 cells compared to JX-0.
  • Tumor suppressor maspin levels tended toward normal in JX-1 cells.
  • Altered expression of heat shock protein 27 (HSP27), glutathione peroxidase (GPX-1), and 14-3-3-sigma was observed.

Conclusions:

  • EGFR signaling significantly impacts the hepatoma cell proteome.
  • Dynamic post-translational modifications may influence hepatoma cell growth.
  • Altered protein expression provides potential targets for therapeutic intervention.